GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (XCNQ:BIOV) » Definitions » FCF Yield %

BioVaxys Technology (XCNQ:BIOV) FCF Yield % : -11.67 (As of Jun. 15, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BioVaxys Technology's Trailing 12-Month Free Cash Flow is C$-1.26 Mil, and Market Cap is C$10.82 Mil. Therefore, BioVaxys Technology's FCF Yield % for today is -11.67%.

The historical rank and industry rank for BioVaxys Technology's FCF Yield % or its related term are showing as below:

XCNQ:BIOV' s FCF Yield % Range Over the Past 10 Years
Min: -60.36   Med: 0   Max: 0
Current: -11.67


XCNQ:BIOV's FCF Yield % is ranked better than
54.32% of 1552 companies
in the Biotechnology industry
Industry Median: -13.865 vs XCNQ:BIOV: -11.67

BioVaxys Technology's FCF Margin % for the quarter that ended in Jul. 2023 was 0.00%.


BioVaxys Technology FCF Yield % Historical Data

The historical data trend for BioVaxys Technology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology FCF Yield % Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
FCF Yield %
- -15.38 -3.94 -15.52 -7.06

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.21 -3.75 -10.50 -48.10 -3.31

Competitive Comparison of BioVaxys Technology's FCF Yield %

For the Biotechnology subindustry, BioVaxys Technology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioVaxys Technology's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's FCF Yield % falls into.



BioVaxys Technology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BioVaxys Technology's FCF Yield % for the fiscal year that ended in Oct. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.575 / 22.306665
=-7.06%

BioVaxys Technology's annualized FCF Yield % for the quarter that ended in Jul. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.024 * 4 / 2.90224
=-3.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioVaxys Technology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BioVaxys Technology FCF Yield % Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (XCNQ:BIOV) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.
Executives
James Passin Director, Senior Officer

BioVaxys Technology (XCNQ:BIOV) Headlines

No Headlines